Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Vbi Vaccines Inc CS (VBIV)

Vbi Vaccines Inc CS (VBIV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 109,381
  • Shares Outstanding, K 97,662
  • Annual Sales, $ 3,360 K
  • Annual Income, $ -63,600 K
  • 60-Month Beta 1.04
  • Price/Sales 37.55
  • Price/Cash Flow N/A
  • Price/Book 1.45

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.14
  • Number of Estimates 1
  • High Estimate -0.14
  • Low Estimate -0.14
  • Prior Year -0.26
  • Growth Rate Est. (year over year) +46.15%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.57 +100.00%
on 06/17/19
2.05 -43.90%
on 05/28/19
-0.89 (-43.63%)
since 05/24/19
3-Month
0.57 +100.00%
on 06/17/19
2.20 -47.73%
on 04/09/19
-0.58 (-33.53%)
since 03/26/19
52-Week
0.57 +100.00%
on 06/17/19
3.00 -61.67%
on 07/13/18
-1.78 (-60.75%)
since 06/26/18

Most Recent Stories

More News
VBI Vaccines to Present at the BMO Capital Markets 2019 Prescriptions for Success Healthcare Conference

VBI Vaccines Inc. (Nasdaq: VBIV) ("VBI"), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced that Jeff Baxter, President...

VBIV : 1.14 (+1.79%)
VBI Vaccines Sees Hammer Chart Pattern: Time to Buy?

VBI Vaccines has been struggling lately, but the selling pressure may be coming to an end soon.

VBIV : 1.14 (+1.79%)
VBI Vaccines Reports Data from Part A of the Ongoing Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma (GBM) Patients at ASCO 2019

EQNX::TICKER_START (NASDAQ:VBIV), EQNX::TICKER_END

VBIV : 1.14 (+1.79%)
All You Need to Know About VBI Vaccines, Inc. (VBIV) Rating Upgrade to Buy

VBI Vaccines, Inc. (VBIV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

VBIV : 1.14 (+1.79%)
VBI Vaccines, Inc. (VBIV) Reports Q1 Loss, Tops Revenue Estimates

VBI Vaccines, Inc. (VBIV) delivered earnings and revenue surprises of 0.00% and 80.00%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

VBIV : 1.14 (+1.79%)
VBI Vaccines Provides Update on GBM Program and Announces Upcoming Conference Call

VBI Vaccines Inc. (NASDAQ: VBIV) ("VBI"), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced:

VBIV : 1.14 (+1.79%)
New Research Coverage Highlights Turquoise Hill Resources, GDS HOLDINGS, AptarGroup, VBI Vaccines, Loral Space and Communications, and FEDNAT HOLDING CO -- Consolidated Revenues, Company Growth, and Expectations for 2019

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Turquoise Hill Resources Ltd. (NYSE:TRQ),...

VBIV : 1.14 (+1.79%)
TRQ : 1.25 (+3.31%)
FNHC : 14.57 (+1.11%)
GDS : 34.46 (+4.74%)
LORL : 33.98 (+0.44%)
ATR : 120.35 (-0.59%)
VBI Vaccines Appoints Joanne Cordeiro to Board of Directors

VBI Vaccines Inc. (NASDAQ: VBIV) ("VBI"), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced the appointment of Joanne...

VBIV : 1.14 (+1.79%)
VBI Vaccines Announces Late-Breaking Poster Presentation at EASL 2019

-- Poster presentation to highlight data from three previously-conducted clinical studies of Sci-B-Vac(R), VBI's prophylactic Hepatitis B vaccine

VBIV : 1.14 (+1.79%)
VBI Vaccines Announces Poster Presentation at the 7th International Congenital CMV Conference & 17th International CMV Workshop

VBI Vaccines Inc. (NASDAQ: VBIV) ("VBI"), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced that David Anderson, Ph.D.,...

VBIV : 1.14 (+1.79%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Good. Long term indicators fully support a continuation of the trend.

See More Share

Trade VBIV with:

Business Summary

VBI Vaccines Inc. is a biopharmaceutical company developing novel technologies to expand vaccine protection. The company's eVLP vaccine platform allows for the design of enveloped virus-like particle vaccines which closely mimic the target virus. Its lead eVLP asset is a prophylactic cytomegalovirus...

See More

Key Turning Points

2nd Resistance Point 1.68
1st Resistance Point 1.40
Last Price 1.14
1st Support Level 0.93
2nd Support Level 0.74

See More

52-Week High 3.00
Fibonacci 61.8% 2.07
Fibonacci 50% 1.79
Fibonacci 38.2% 1.50
Last Price 1.14
52-Week Low 0.57

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar